SAMUEL SILVA: Open Payments
NPI 1477964344 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,159 in 18 payments from 9 companies in 2025. Trend: 2023 $1,967 · 2024 $102 · 2025 $1,159
Travel & lodging: $692Food & beverage: $467
| Company | Payments | Amount |
|---|---|---|
| Arthrex, Inc. | 7 | $626 |
| POLARIS TECHNOLOGY SOLUTIONS LLC | 2 | $269 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $64 |
| Smith+Nephew, Inc. | 1 | $49 |
| Ferring Pharmaceuticals Inc. | 2 | $41 |
| Davol Inc. | 1 | $34 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $34 |
| Bioventus LLC | 1 | $21 |
| Amgen Inc. | 1 | $20 |
Products named: ENTYVIO, EUFLEXXA, ARISTA, JOURNAVX, GELSYN-3, EVENITY.
Industry payments across CT — which companies pay providers there.
